Observational analysis found low serum total cholesterol is linked to higher heart failure rates in myeloproliferative neoplasms, suggesting revised cholesterol management may be needed.
Key Points
Lower serum total cholesterol is associated with increased risk of heart failure hospitalization and adverse hematologic outcomes.
Among 305 patients, those with total cholesterol below median showed 2.45 times higher risk of hematologic progression.
Analysis of a multicenter registry included transthoracic echocardiogram data to assess cardiovascular disease outcomes.
Results indicate that traditional cholesterol targets may not apply to patients with myeloproliferative neoplasms, highlighting the need for tailored approaches.